Vancocin Capsule
NDC Package 62559-310-20
Package Information
Vancocin (vancomycin hydrochloride) capsules is vANCOCIN CAPSULES are indicated for the treatment of C. This formulation utilizes a capsule delivery system. Marketed by Ani Pharmaceuticals, Inc., this product is identified by NDC 62559-310 and is authorized under FDA application NDA050606.
Identification & Billing
- RxCUI: 201848 - Vancocin 125 MG Oral Capsule
- RxCUI: 201848 - vancomycin 125 MG Oral Capsule [Vancocin]
- RxCUI: 201848 - Vancocin (as vancomycin hydrochloride) 125 MG Oral Capsule
- RxCUI: 201849 - Vancocin 250 MG Oral Capsule
- RxCUI: 201849 - vancomycin 250 MG Oral Capsule [Vancocin]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 62559 - Ani Pharmaceuticals, Inc.
- 62559-310 - Vancocin
- 62559-310-20 - 2 BLISTER PACK in 1 CARTON / 10 CAPSULE in 1 BLISTER PACK
- 62559-310 - Vancocin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62559-310-20 identifies a specific commercial package of 2 blister pack in 1 carton / 10 capsule in 1 blister pack of Vancocin, a human prescription drug labeled by Ani Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 2 billable units per package. This capsule is formulated for oral use and contains vancomycin hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ani Pharmaceuticals, Inc. on November 17, 2014. The current certification is valid through December 31, 2026.
How is this Ani Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62559031020. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.